These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection of p16INK4a promoter methylation status in non-small cell lung cancer by a fluorescence polarization assay. Song Z; Zhou R; Li D; Chen Y; Liang P; Liu W; Zhang J Diagn Mol Pathol; 2011 Sep; 20(3):138-42. PubMed ID: 21817906 [TBL] [Abstract][Full Text] [Related]
3. EGFR promoter methylation detection in cervical cancer by a hybridization-fluorescence polarization assay. Zhang W; Gao Y; Jiang Y; Ping L; Cheng H; Zhang J Diagn Mol Pathol; 2013 Jun; 22(2):102-6. PubMed ID: 23628821 [TBL] [Abstract][Full Text] [Related]
4. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis. Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490 [TBL] [Abstract][Full Text] [Related]
5. Status of O⁶ -methylguanine-DNA methyltransferase [MGMT] gene promoter methylation among patients with glioblastomas from India. Nehru GA; Pai R; Samuel P; Chacko AG; Chacko G Neurol India; 2012; 60(5):481-6. PubMed ID: 23135024 [TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53. Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750 [TBL] [Abstract][Full Text] [Related]
7. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569 [TBL] [Abstract][Full Text] [Related]
8. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas. Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875 [TBL] [Abstract][Full Text] [Related]
9. Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase. Lavon I; Fuchs D; Zrihan D; Efroni G; Zelikovitch B; Fellig Y; Siegal T Cancer Res; 2007 Sep; 67(18):8952-9. PubMed ID: 17875738 [TBL] [Abstract][Full Text] [Related]
10. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694 [TBL] [Abstract][Full Text] [Related]
11. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591 [TBL] [Abstract][Full Text] [Related]
12. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression. Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543 [TBL] [Abstract][Full Text] [Related]
13. Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin. Park CK; Park SH; Lee SH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW Neuropathology; 2009 Aug; 29(4):443-9. PubMed ID: 19170894 [TBL] [Abstract][Full Text] [Related]
14. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Hattermann K; Mehdorn HM; Mentlein R; Schultka S; Held-Feindt J Anal Biochem; 2008 Jun; 377(1):62-71. PubMed ID: 18384736 [TBL] [Abstract][Full Text] [Related]
15. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230 [TBL] [Abstract][Full Text] [Related]
16. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP. Kristensen LS; Nielsen HM; Hager H; Hansen LL Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446 [TBL] [Abstract][Full Text] [Related]
17. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma. Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111 [TBL] [Abstract][Full Text] [Related]
18. Decreased expression of MGMT in correlation with aberrant DNA methylation in esophageal cancer patients from North India. Rehman AU; Saikia S; Iqbal MA; Ahmad I; Sadaf ; Anees A; Aravinda PS; Mishra PK; Hedau S; Saluja SS; Medhi S; Husain SA Tumour Biol; 2017 Jun; 39(6):1010428317705770. PubMed ID: 28621225 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinicopathologic correlates of O⁶-methylguanine-DNA methyltransferase methylation status in patients with triple-negative breast cancer treated preoperatively by alkylating drugs. Fumagalli C; Della Pasqua S; Bagnardi V; Cardillo A; Sporchia A; Colleoni M; Viale G; Barberis M; Pruneri G Clin Breast Cancer; 2014 Aug; 14(4):285-90. PubMed ID: 24709436 [TBL] [Abstract][Full Text] [Related]
20. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients. Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]